You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API ethosuximide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ethosuximide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 D&C YELLOW NO. 10
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 FD&C RED NO. 3
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 GELATIN
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 GLYCERIN
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 POLYETHYLENE GLYCOL 400
Parke-Davis Div of Pfizer Inc ZARONTIN ethosuximide 0071-0237 SORBITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing ethosuximide

Company Ingredient NDC Excipient
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 CITRIC ACID MONOHYDRATE
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 FD&C RED NO. 40
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 FD&C YELLOW NO. 6
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 GLYCERIN
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 SACCHARIN SODIUM
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418 SODIUM BENZOATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ethosuximide

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BUTYL ALCOHOL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIMETHICONE

Excipient focus: ETHYL MALTOL

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYPROMELLOSE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

ethosuximide drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION

Company Ingredient NDC
Parke-Davis Div of Pfizer Inc ethosuximide 0071-0237
Parke-Davis Div of Pfizer Inc ethosuximide 0071-2418
PAI Holdings LLC dba PAI Pharma ethosuximide 0121-0670
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc ethosuximide 23155-532
Epic Pharma LLC ethosuximide 42806-708
Epic Pharma LLC ethosuximide 42806-711
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: RASPBERRY

Excipient focus: SACCHARIN SODIUM

Excipient focus: SACCHARIN SODIUM ANHYDROUS

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBITOL

Excipient focus: SUCROSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links